Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein cysteine thiol groups are the sulfhydryl-containing side chains of cysteine residues that serve as critical reactive centers within the proteome. These groups are essential for maintaining protein structure through disulfide bond formation and are vital for the catalytic activity of various enzymes, such as cysteine proteases and phosphatases (Chung et al., 2013, Molecular Cell). Beyond structure and catalysis, cysteine thiols act as molecular switches in redox signaling, where their oxidation state regulates protein function in response to cellular oxidative stress (Go & Jones, 2013, Free Radical Biology and Medicine). In pharmacology, these thiols are the primary targets for covalent inhibitors, which utilize electrophilic "warheads" to form stable, irreversible bonds with specific cysteine residues in proteins like Bruton's tyrosine kinase (BTK) or the Epidermal Growth Factor Receptor (EGFR) (Singh et al., 2011, Nature Reviews Drug Discovery). While this targeting strategy provides high potency and prolonged duration of action, it also carries risks of off-target reactivity and potential immunogenicity if the drug modifies unintended proteins (Nara et al., 2014, Journal of Medicinal Chemistry). Consequently, protein cysteine thiols represent a versatile and high-impact class of reactive sites for both endogenous regulation and therapeutic intervention.
Covalent modification of the nucleophilic sulfur atom through Michael addition, SN2 alkylation, or disulfide exchange (Singh et al., 2011, Nature Reviews Drug Discovery).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein cysteine thiol groups (PSH).